Description

1-Piperazinecarboxamide,4-(3-Cyano-7-Methoxy-2-Quinolinyl)-n-Phenyl-(9Ci) is a sophisticated heterocyclic organic compound featuring a quinoline core linked to a phenyl-substituted piperazinecarboxamide moiety. This molecular architecture makes it a critical intermediate in advanced pharmaceutical research and development, particularly for targeting specific biological pathways. It is primarily required by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of novel active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of potential drug candidates, especially in oncology and central nervous system (CNS) therapeutic areas.
• Kinase Inhibitor Research: Serves as a core scaffold for the development of novel kinase inhibitors due to its quinoline structure.
• Chemical Biology Probes: Used in the design and synthesis of molecular probes for studying enzyme function and cellular signaling pathways.
• High-Purity Reference Standard: Supplied as a certified reference material for analytical method development and quality control in API manufacturing.
• Custom Synthesis: A starting material for contract research organizations (CROs) and CDMOs performing bespoke synthetic routes for clients.
• Academic Research: Utilized in university and institutional labs for medicinal chemistry programs and novel heterocyclic compound exploration.

Basic Information

Product Name	1-Piperazinecarboxamide,4-(3-Cyano-7-Methoxy-2-Quinolinyl)-n-Phenyl-(9Ci)
CAS No.	603970-42-9
Molecular Formula	C22H21N5O2
Molecular Weight	387.44 g/mol
Synonyms	4-(3-Cyano-7-methoxyquinolin-2-yl)-N-phenylpiperazine-1-carboxamide; N-Phenyl-4-(7-methoxy-3-quinolinecarbonitrile-2-yl)piperazine-1-carboxamide; 4-(3-Cyano-7-methoxy-2-quinolyl)-N-phenyl-1-piperazinecarboxamide; UNII-9P5H8B8U4F; 9CI-603970-42-9; 2-Quinolinecarbonitrile, 4-(3-cyano-7-methoxy-2-quinolinyl)-N-phenyl-1-piperazinecarboxamide derivative
EINECS	Contact for details

Quality Control

Our high-purity pharmaceutical intermediate is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) with detailed chromatographic data are provided for each lot, supporting its use in regulated research and development environments.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound may be light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.